EMERGING QUALITY CONTROL PERSPECTIVES FOR AYURVEDIC DRUG by Rajeev, *Kurele et al.
AYUSHDHARA            ISSN: 2393-9583 (P)/ 2393-9591 (O) 
 An International Journal of Research in AYUSH and Allied Systems 
AYUSHDHARA | November - December 2016 | Vol 3 | Issue 6  936 
 
     
  
 
EMERGING QUALITY CONTROL PERSPECTIVES FOR AYURVEDIC DRUG 
Kurele Rajeev1*, B Srinivasulu2, Katoch Dinesh3, Dhiman KS4, Joshi V.K.5, Prajapati PK6 
*1Manager QC, QA and F&D, Person-in-charge, AYUSH DTL (Govt. Approved Lab.), Indian Medicines Pharmaceutical 
Corporation Limited, (A Govt. Of India Enterprise under ministry of AYUSH), Mohan, Almora, Uttrakhand, India. 
2Reader, Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre, Shobhit University, Gangoh, 
Saharanpur, Uttar Pradesh, India. 
3Advisor (Ayurveda), Ministry of AYUSH, Govt. of India, New Delhi, India.   
4DG, CCRAS, Ministry of AYUSH, Govt. of India, New Delhi, India.    
5Ex.-Dean, IMS, Banaras Hindu University, Varanasi. Chairman of Ayurvedic Pharmacopoeia Committee 
6Head of Department, Rasa Shastra & Bhaishjaya Kalpna, All India Institute of Ayurveda , New Delhi, India.  
 
KEYWORDS: AYUSH, ASU Drugs, 


















Ayush system of medicines based Herbal Pharmaceutical industry (ASU & H drug 
mfg) is having great potential and opportunities in India for development in 
future because of global acceptability of the medicinal plants & their value added 
products in Domestic & International Market as Ayurvedic, Unani and Siddha 
medicines, Herbal Nutraceuticals, Herbal Cosmoceutical, Herbal Health drinks, 
Dietary Health Supplements, Medicinal Plants / Crude Drugs, Herbal Extracts / 
Concentrates, Veterinary Medicines, Health Foods. India is rich with 771468 
registered Ayush practitioners, 8667 licensed Ayurvedic drug manufacturing 
units. Quality Control/Assurance is the department, which controls all activities 
at various level of manufacturing as National & International standard. Ministry 
of Ayush continues to lay emphasis on up gradation of AYUSH educational 
standards, Quality control and standardisation of drugs, improving the 
availability of medicinal plant material, research and development and 
awareness generation about the efficacy of the system domestically and 
internationally. There are various issues & challenges related to drug quality for 
ASU&H Pharmaceutical Industries in India. It needs proper attention of policy 
makers and regulator & academia. Complete Implementation of GMP (schedule 
T) norm/guidelines and quality control/assurance procedure and activities is a 
big challenge for ensuring quality of drug. 
INTRODUCTION 
Opportunities for Ayurvedic Medicines 
 Ayush system[1] of medicines based Herbal 
Pharmaceutical industry (ASU & H drug mfg) is having 
great potential and opportunities in India for 
development in future because of global acceptability of 
the medicinal plants & their value added products in 
Domestic & International Market[52-53] as Ayurvedic, 
Unani and Siddha medicines, Herbal Nutraceuticals, 
Herbal Cosmoceutical, Herbal Health drinks, Dietary 
Health Supplements, Medicinal Plants / Crude Drugs, 
Herbal Extracts / Concentrates, Veterinary Medicines, 
Health Foods. India is rich with 771468 registered Ayush 
practitioners (as on 1.4.2016)[2] in India; out of these 
419217 (54.4%) belong to Ayurveda and there were 
8667 licensed Ayurvedic drug manufacturing units(as on 
1.4.2016) in the country; out of these 99.5 % were 
controlled by non Govt bodies eg. Ayurvedic drug now 
day to become more popular globally.[3] There may be 
several positive causes of global popularities & 
acceptance of herbs based Ayurvedic drugs. e.g. 1.Easy 
accessibility & approach for Ayurvedic drug mostly time 
tested for their efficacy. 2. Cost effective and affordable. 
3. Most of ISM drugs of Herbal origin are safe to use. 
“Assume to be no side effect”. 4. Increasing awareness 
about AYUSH systems due to it emphasize on Prevention 
of Diseases & Promotion of Health as it Considered Body, 
Mind and Soul as one unit & Ayush Healthcare also 
provided complete Disease management. 5. Increasing 
public awareness for adverse effects of synthetic drugs 
Total Global Market of herbal product[4] Natural 
Products) is estimated aprox. 62 billion USD($)[5]. The 
Compounded annual growth of Pharmaceutical 
industry[6] is estimated as 17.8%. Assumption By 2050 
herbal market is expected to reach US $ 5 trillion Worth 
of Domestic market[7] of Ayurvedic, Siddha, Unani and 
Homeopathy Medicines is estimated by 15000-20000 
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Crore (Classical Ethical product (P&P) OTC Herbal 
Cosmetic) of which Classical AYUSH medicines market is 
estimated to be about 1000-1500 Crore. Ayurvedic 
Medico tourism market is estimated by Assocham is 
>800 crore. According to the information compiled by 
Pharmexil the “India’s total export value of herbals was 
2437.377 USD Million” and “total import value of herbals 
was 175 USD Million”  
Ministry of AYUSH, Govt. of India 
 The Ministry of AYUSH[8] was formed on 9th 
November' 2014. Earlier it was known as the 
Department of Indian System of Medicine and 
Homeopathy (ISM&H) which was created in March 1995 
and renamed as Department of Ayurveda, Yoga and 
Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) 
in November 2003, with a view to provide focused 
attention for the development of Education and Research 
in Ayurveda, Yoga and Naturopathy, Unani, Siddha and 
Homoeopathy.  
Objectives of Formation of AYUSH Ministry[9]  
1. To upgrade the educational standards of Indian 
Systems of Medicines and Homoeopathy colleges in 
the country. 
2. To strengthen existing research institutions and to 
ensure a time-bound research programme on 
identified diseases for which these systems have an 
effective treatment. 
3. To draw up schemes for promotion, cultivation and 
regeneration of medicinal plants used in these 
systems. 
4. To evolve Pharmacopoeial standards for Indian 
Systems of Medicine and Homoeopathy drugs. 
Ayurvedic System of Medicines 
 Ayurveda[10] is a word made of Ayu = Life and 
Veda = knowledge; which means a particular branch 
which tells about the knowledge of Ayu. In the beginning 
of Creation as per theory of evolution it is presumed that 
first of all plants come into existence , followed by 
animals. Ayurveda is the natural healing system of India, 
which literally means ‘the science of Life’. 
 According to Ayurveda “The Life is result of 
better combination & coordination of Satva (mind), Atma 
(Soul), Indriya (Sense Organ); Every person want good 
health because Heath (Arogya) is base of Chatur-
Purusharth-Dharma, Artha, Kama, Moksha. Life in 
Ayurveda is conceived as the union of body, senses, mind 
and soul. The living man is a made up from the three 
humours (Vata, Pitta & Kapha), seven basic tissues (Rasa, 
Rakta, Mansa, Meda, Asthi, Majja & Shukra) and the waste 
products of the body such as faeces, urine and sweat. 
According to Surshruta “ Sama dosa, Sama Agni, Sama 
Dhatumal kriya, Prasana Atmaendriyaman Svasthyaiti-
dhiyate” As per Ayurveda general haealth of individual 
person is directly related to proper equilibrium of The 
Sttambha of Body (Vatta, Pitta, Kapha) & Ahar (diet), 
Nidra (proper sleep), Brimhchariya, which are well 
known as Upastmbha of life. They play very important 
role in the operation of life (Ayu), Improper utilization of 
these make body diseased. For this Ayurveda emphasis 
on preserving and promotion of health of individuals as 
well as on the treatment of illness through natural 
resources. Its diagnostic method, therapeutic 
procedures, the use of drug formulation(by combination 
of herbs, plants, trees, mineral, metals & animal product 
as per diseases) with their dosage and manner of taking 
were all very systematized, based on long standing 
observations & experience of the our ancient Achariya. 
Production Process/Operation Management 
 Production/operations management[11] (P/OM), 
as a functional field of management, has developed 
rapidly during the last 15 years. As consumers have 
become more discerning and competition more intense, 
manufacturing organizations have been presented with a 
wide variety of panaceas including; just-in-time (JIT), 
total quality management (TQM), manufacturing 
resources planning (MRP II), flexible manufacturing 
systems (FMS) and computer-integrated manufacturing 
(CIM), ISO, Six Sigma process Approach etc. 
 The general process involved in the manufacture 
of drug products consists of a series of unit 
operations/process, each intended to modulate certain 
properties of the material being processed[12] for 
example Ayurvedic tablet manufacturing require 
following manufacture process step to product tab eg. 
Material Procurement, Mtl. Storing, Material Indenting, 
Weighting, Preprocessing (Cleaning, Grading, chopping, 
Cutting,), Size reduction, Dry Mixing, Wet mixing, drying, 
Milling, Sieving, Sizing, lubrication, tab compression, 
Coating, Primary packing, Secondary packing etc. The 
manufacture of drug substance, or API (active 
pharmaceutical ingredient), involves several unit 
operations/processes. Typically, it involves several 
stages of complex traditional process/reactions as per 
classical Ayurvedic texts or Ayurvedic pharmacopoeia. In 
which different functional groups are attached to the 
starting raw material. The products formed after each 
stage of reaction are termed as intermediates. In many 
cases, some downstream processing of the reaction 
mixture such as filtration, distillation etc. is also 
conducted prior to the next reaction step. The final 
reaction mixture or finished goods/medicines, also 
termed as the powder, Decoction, Extract, mother liquor, 
goes through multiple steps of downstream processing to 
produce the desired active in solid form – Tab , Powder, 
Granules, Capsule, Syrup, Cream, ointment Asava, 
Arishtha, Avleha etc. These steps almost always include 
Size reduction, Mixing/Homogenation filtration, 
distillation, precipitation (reactive crystallization), 
crystallization, drying and milling. 
Quality Control/Assurance for ASU Drug Industry 
 Quality Control/Assurance is the department, 
which controls all activities at various level of 
manufacturing as National & International standard. 
Quality Control is a part of quality management focused 
on full filling quality requirement. Quality Assurance 
providing confidence that quality requirement will be 
fulfilled. QC is defect detection & product oriented 
however QA is defect prevention & process oriented. QC 
is actually testing process and QA is its verification  
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 Ministry of Ayush continues to lay emphasis on 
up gradation of AYUSH educational standards, Quality 
control and standardization of drugs, improving the 
availability of medicinal plant material, research and 
development and awareness generation about the 
efficacy of the system domestically and internationally.  
 There are various issues & challenges related to 
drug quality for ASU&H Pharmaceutical Industries in India. 
It needs proper attention of policy makers and regulator & 
academia. Complete Implementation of GMP (schedule T) 
norm/guidelines and quality control/assurance procedure and 
activities is a big challenge for ensuring good quality of 
drug; hence we first need to understand what is quality. 
What is Quality? 
 Word “Quality’ derived from Latin word ‘quails” 
means of which kind. Quality is denominator of a product 
or its acceptability to consumers & regulatory authority. 
It is degree to which a “set of inherent characteristics 
that fulfil customer requirement. Reasons for quality 
becoming a cardinal priority for most organizations as[13] 
• Competition – Today’s market demand high quality 
products at low cost. Having `high quality’ 
reputation is not enough! Internal cost of 
maintaining the reputation should be less. 
• Changing customer – The new customer is not only 
commanding priority based on volume but is more 
demanding about the “quality system.” 
• Changing product mix – The shift from low volume, 
high price to high volume, low price have resulted 
in a need to reduce the internal cost of poor quality. 
• Product complexity – As systems have become 
more complex/integral, the reliability requirements 
for suppliers of ingredients have become more 
stringent. 
• Higher levels of customer satisfaction – Higher 
customer’s expectations are getting spawned by 
increasing competition. 
What is Quality Control-Control on entire production 
process with the set-norm/Standards is carried out by 
the Quality Control/Assurance[13] Department. QC/QA is 
the department, which controls all activities at various 
level of manufacturing as National & International 
standard. 
Quality Control 
QC is a part of quality management focused on full filling 
quality requirement. 
Quality Assurance  
QA providing confidence that quality requirement will be 
fulfilled.  
QC is defect detection & product oriented however QA is 
defect prevention & 
Process oriented. QC is actually testing process and QA is 
its verification. [13]  
Production Process & Quality Control: Relevance for 
Pharmaceutical Industry 
 Ayurvedic Industry comes under schedule “T” of 
Drug & Cosmetic Act 1940 & Rule the under 1945[14]. It 
have certain guidelines for production process and their 
quality control which are collectively known as GMP. [15] 
 Quality Control is the part of GMP concerned 
with sampling, specifications and testing, and with the 
organization, documentation and release procedures 
which ensure that the necessary and relevant tests are 
actually carried out and that materials are not released 
for use, nor products released for sale or supply, until 
their quality has been judged to be satisfactory. Quality 
control is not confined to laboratory operations but must 
be involved in all decisions concerning the quality of the 
product. 
Customers -General Quality Perspectives 
 As Ayurvedic classics[18] “Bhisak, Dravya, 
Upasthata, Rogi Pad Chatushthyam” mean Bhisak (Vaidya 
/Ayurvedic. Physician), Dravya (Drugs), Upasthata 
(supporting staff), Rogi (patient) are the main four pillar 
of Ayurvedic system of medicines. All should be good as 
per described Guna. Vaidyas are technically skilled for 
Ayurvedic treatment concept as well knows to how drug 
manufacturing. In old time medicines was prepared by 
Vaidya itself by taking/collecting highest quality Raw 
material; mostly in fresh form and dispensed at the same 
time. That time there is no issues about drug efficacy 
quality, preservation, safety, issues etc. time has been 
passes. Medicines prepared by commercial 
manufacturing house. It involve third party other than 
user (customer). That why customer looks fulfilling their 
product requirement. Relatively simpler approaches to 
quality viz. product inspection for quality control and 
incorporation of internal cost of poor quality into the 
selling price, might not work for today’s complex market 
environment. Everyone defines Quality based on their 
own perspective of it. Typical responses about the 
definition of quality would include: [16] 
1. Perfection 
2. Consistency 
3. Eliminating waste 
4. Speed of delivery 
5. Compliance with policies and procedures 
6. Doing it right the first time 
7. Delighting or pleasing customers 
8. Total customer satisfaction and service 
Why QC/QA Needed 
There are several reason for requirement of QC/QA 
Implementation in Ayurvedic Pharmaceutical industry as 
it is needed for 
 Identification of drug 
 Purity of drug 
 Safety of drug 
 Strength of drug 
 Efficacy of drug 
 For Ayurvedic Physician, To cure disease, drug is 
only tool, So, medicine would be good in quality & 
high standard. 
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 The product meets the standards and expectations 
of medical professionals and regulatory agencies 
around the world. 
 The product performs as claimed. 
 The product can be successfully made consistently. 
 To follow GMP/GLP/WHO[19-20] CoPP/ISO etc. 
standards Given by regulatory agencies/authority 
Sections Works Under Q.C/QA 
Q.C. work every where throughout manufacturing 
processor for producing good quality product by 
following three department 
 Department of Pharmacognosy  
 Department of Chemistry 
 Department of pharmacology 
 Department of Microbiology 
Methodology of Q.C./QA 
The quality assessment tests is carried out by Quality 
control and Quality assurance Dept. during the drug 
manufacturing can be done in three main stages under 
GMP and GLP norms. 
 proper Sampling and testing of raw material only 
good quality material are accepted otherwise 
substandard material rejected. 
 Sampling and testing of mid products(extracts 
etc.) at different stages.  
 In process Quality control during Production for 
such controlled parameter like-Temperature, 
Relative humidity (RH), pressure Etc.  
 Sampling and testing of finished products 
(powder, tablets, Bhasmas etc.). 
A) Methodology of Testing of Crude Drugs 
 The quality assessment shall be done by Quality 
control and Quality assurance Department through 
proper sampling as per sampling plan. Sample should be 
taken before production; only complies material with 
regard to standards laid down in pharmacopeia/In-
house protocol should be releases for production.  
Testing Protocol of Raw drugs (as per API/UPI 
Monograph/testing protocol) [21-34 && 42-45] 
a) Identity- 
i) Pharmacognosy Profile (Macroscopic/ Microscopic) 
Macroscopic examination: Visual examination as 
Size, Colour, Surface, Characteristics, Texture and 
Other examination as Odour, Taste. 
Macroscopic examination: Preparation of sample, 
Inspection by microscopy, Inspection by colour filter 
of ground glass, Histo-chemical detection, Section 
study(T.S./L.S.). 
ii) Chemical identification  
iii) TLC/ HPTLC FP profile 
b) Purity-Physico-Chemical profile (as above as 
applicable as per dosage form). 
c) Strength-Active marker/Assay (wherever required) 
d) Safety –  
i)Heavy metal profile (Lead, Mercury, Arsenic, Cadmium)  
ii) Microbiological limit testing (Total Aerobic Bacterial 
count, Total yeast /mould count and Presence of 
pathogens [Salmonella, P. aeruginosa, E.coli, S. aureus ])  
 iii) Aflatoxins (B1, B2, G1, G2) 
iv) Pesticide residue 
B) Methodology of Testing of Compound Drugs  
 The quality assessment shall be done by Quality 
control and Quality assurance Department through 
proper sampling as per sampling plan. Sample should be 
taken from In-process stage and finished product from 
Quarantine area. Only complies finished product with 
regard to standards laid down in pharmacopeia/In-
house protocol should be releases for dispatch for end 
user. 
 QC/QA Technical person should also ensure 
about compliance of other regulators requirement such 
as Label claim under rule 161 of drug & cosmetic act. As 
drug name, formulation & composition, Drug mfg Ref, 
main therapeutic indication/uses, dose, vehicle, direction 
of use (if any), self life, caution/warning (if any), storage 
condition etc. 
Testing Protocol of drugs (as per API/UPI 
Monograph/ testing protocol) [35-41 & 42-45] 
a) Description 
b) Identity-Pharmacognosy Profile (Macroscopic/ 
Microscopic- wherever required) 
  Chemical identification (Wherever required) 
  TLC/ HPTLC FP profile (Wherever required) 
c) Purity-Physico-Chemical profile* (as above as 
applicable as per dosage form) 
d) Strength-Active marker/Assay (wherever 
required) 
e) Safety –  
i) Heavy metal profile (Lead, Mercury, Arsenic, 
Cadmium)  
ii) Microbiological limit testing (Total Aerobic Bacterial 
count, Total yeast /mould count and Presence of 
pathogens [Salmonella, P. aeruginosa, E.coli, S. aureus])  
iii) Aflatoxins (B1, B2, G1, G2) 
iv) Pesticide residue 
 There are various physicochemical testing 
employed for drug profiling which is depend on the 
specific characteristics of drug/dosage form or testing 
protocols given in Ayurvedic Pharmacopoeia of India 
(API), Unani Pharmacopoeia of India (UPI), Siddha 
Pharmacopoeia of India (SPI), USP (United state 
Pharmacopoeia), IP (Indian Pharmacopoeia) etc as 1) 
Determination of foreign matter, 2) Determination of Ash 
value (at 500-8000C), 3) Determination of extractable 
matter, 4) Determination of water & volatile matter, 5) 
Determination of Moisture content (L.O.D. at 1100C) 6) 
Determination of bitterness value, 7) Determination of 
haemodynamic activity, 8) Determination of Tannins, 9) 
Determination of swelling index, 10) Determination of 
foaming index, 11) Determination of pesticide residue, 
12) Determination of Total chlorine & phosphorous, 
phosphates, 13) Determination of arsenic & Heavy Metal, 
14) Determination of Bulk density, 15) Determination of 
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Radio-active contamination, 16) Comparative TLC/ 
HPLC/ HPTLC/GC-MS, 17) Determination of in-organic 
content by ICP etc various tests may be carried out for 
Quality control as per need according to dosage from.  
 Stability study also be carried out for QC/QA 
work for 1) Real time Stability studies (to see the 
changes in the quality standards at various intervals is 
found suitable for ascertaining the shelf life of the ASU 
medicines) in standard Storage Condition- Temp. 300C ± 
20C, Relative Humidity: 60% ± 5 % for 1/6/12/18/24 
/30/36months as per stability study testing protocol 
Instruments used in QC/QA Process 
 Various common instrument used in the quality 
control/Assurance activities as Ph meter, Single 
Distillation unit, Double distillation unit, Soxhelet 
assembly, Water bath, Viscometer, Tinto meter, Bulk 
density apparatus, Polari meter, Referectometer, 
Microscope, Titration unit, Hot air oven, Magnetic stirrer, 
Filtration unit, I.R. Moisture balance, Karl fischer 
tritrator, Muffle furnace, Vacuum evaporator, Dissolution 
apparatus, Friability apparatus, Hardness tester, Top 
loading balance, Autoclave, B.O.D., Incubator, Laminar 
flow, Microbiological colony counter, Antibiotic Zone 
Reader. In drug standardization work so many 
ultramodern instrument also used frequently as & when 
they are application as Paper chromatography setups, 
Column Chromatography apparatus, Double beam 
Spectrophotometer, HPTLC Unit, HPLC Unit, LCMS, G.C. 
with detector, GCMS, ICP-MS etc. 
Documentation Required for QC/QA  
 Documentation is a reliable (written) record that 
can be used, at a future time, to clearly and completely 
recreate an activity, event, or process. There are several 
Documentation Rules as Use permanent blue or black 
ink, Record information directly on proper form, Record 
information immediately after completion of step, 
process, or observation, Use proper date and signature 
formats, Correct ‘errors in documentation’ promptly and 
properly. There are 9 Characteristics of a properly 
produced Document as Permanent, Legible, Accurate, 
Prompt, Clear, Consistent, Complete, Direct, and Truthful. 
 In manufacturing unit, QC, QA dept. should be 
maintained following record & documentation. eg. 
Sample receiving register, Reagent & chemical stock 
register, Lab. Manual, Quality plan, Instrument manual 
and SOPs (standard operating Procedures) for 
Instrument Handling & maintenance, STP (Standard 
Testing Procedures), Instruments logbook, Calibration 
records, reagent/solution standardization record, and WI 
(Work instruction having knowledge of OQ (Operation 
Qualification), IQ (Installation Qualification), DQ (Design 
Qualification), PQ (Performance Qualification) , QC, QA 
Technical person must know state of art instrumentation 
technique. 




3. Standards /References 
4 Specifications 
Procedure: 
1.Laboratory test manual 
2. Standard Testing Procedures (STP) 
3. Standard operating Procedures (SOP) 
4. Work Instruction 
Maintaining: 
1. Standardization  
2. Calibration 
3. Verification 
Out Put: - Test Reports (COA) 
Step Taken by M/O Ayush for Improving Quality of 
ASU& H Drugs 
 Various solid steps[47-51] have been taken for 
Improvement in drug quality by strengthening of drug 
enforcement /regulation by Ministry of AYUSH, Govt. of 
India in last decade for mainstreaming Ayush system of 
medicines in India as. 
 Separate chapter and rules for Ayurveda, Siddha and 
Unani drugs in Drugs & Cosmetics Act, 1940. 
 Drug Technical Advisory Board (ASUDTAB) for 
matters related to quality control and 
standardization. 
 Drugs Consultative Committee (ASUDCC) for 
securing uniform administration of the legal 
provisions in different states.  
 Licensing of manufacturing units and drugs 
mandatory.  
 Compulsory Good Manufacturing Practices (GMP) 
schedule “T”. 
 Central Government empowered to prohibit 
manufacture and sale of certain drugs in public 
interest. 
 Government Drug Analysts- Qualifications and 
Duties. 
 Appointment of Drug inspectors. 
 Penalty for manufacture, sale etc. of drugs in 
contravention of Act.  
 To prescribe methods of drug testing and analysis. 
 Listing of schedule E drugs – poisonous materials. 
 Definition of misbranded, adulterated and spurious 
drugs for punitive action. 
 Labelling/Packing provisions under rule 161 of 
Drugs & Cosmetics Act. 
 Establishment of research councils eg. CCRAS, 
CCRUM, CCRH, CCRS) for quality research and 
development of pharmacopeial standards.  
 Establishment IMPCL for mfg pure & authentic drug 
as per pharmacopeia for Govt. supply. 
 Recognition of private and public drug testing 
laboratories (39) for sample analysis. 
 Compulsory testing and Certification for export.  
 Approval for separate ASU & H drug controller. 
 Various initiative taken by Govt under COE, IC, NMPB 
scheme of Ayush Ministry. 
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 Establishment of PLIM, HPL, State DTL (27), Latest 
setup of PCIM&H. 
 Regulation of Drug Control cell & Implementation of 
API/UPI/SPI/HP of Raw Materials as well as finished 
Medicines. Publication of AFI, NFUM for drug 
manufacturer for the consistent & uniform quality of 
the drug.  
General Difficulties/Challenges for Q.C. Activities [46-
53] 
 Lack of awareness & up to date knowledge of QC/QA 
procedures & GMP norm. 
 Lack of Up to date Infrastructure / state of the art 
machinery, automation in process, Technical 
manpower, Poor Formulation & Development (F & 
D) initiatives for process & product development.  
 Instrument & basic setup as per GMP is too costly. 
 Poor R & D activities and lack of Awareness in the 
field of R & D in Ayurveda. 
 Raw drug unavailability in proportion of demand. 
 Availability of Authentic Raw materials. Various 
Adulteration/spurious/legal drug issues. 
 Increasing number of endangered medicinal 
plants(Red Data Book). 
 Commercialization (High cost of product) Drug 
Adulteration.  
 Availability of Skilled technical traditional Ayush 
professional with scientific background. 
 Lack of Scientific documentation, SOPs, STPs, CCP 
(Critical control Point), Validated data on drug 
Manufacturing. 
 Lack of Process and Product standardization & 
Validation date. 
 Lack of complete drug standards. Limitation in 
standards of raw material and finished product.  
 Everywhere Commercialization even with the drug, 
which is the need of health; One’s need to be work 
with oriented motto/charity for human welfare; 
rather than business oriented approach which 
makes product adulterated/spurious. It needs 
implementation of GMP, Ayush mark, QCI, GLP, GPP, 
GAP, GCP, Organic certification etc. on ground levels. 
It will require investment at initial level. 
 Comparative Poor Statutory regulation as allopathic 
drug, Shortage of Drug enforcement infrastructure & 
manpower. 
Role of Govt. to regularize Q.C. Activities 
 The national health authorities (Ministry of 
AYUSH, Govt. of India and State Licensing Authorities/ 
Drug controller) should ensure that all ASU &H Drugs 
subject to their control are in conformity with Quality, 
Safety, Efficacy and that all premises and practices 
employed the, manufacturing and distribution of these 
product comply with GMP standards, So as to ensure the 
continued conformity of the product with these 




 In view of the cited facts we can conclude & way 
forwards for ISM drug mfg industry or AYUSH Academia 
as  
 The global interest in traditional medicine of India 
especially Ayurveda is increasing with the result of 
that herb based single and compound formulations 
market is growing very fast. 
 The international and national ministries/ 
organization/institutions have emphasized on 
quality products for safe use by the consumers. 
Therefore, mandatory regulations for authentic 
use of herb under legal provisions of respective 
countries have been imposed. 
 Govt must be re-structuring & strengthen the 
existing Drug enforcement infrastructure. 
 We should promote cultivation of MAPs (Medicinal 
& Aromatic Plant) & Development of Common raw 
material sourcing centre (Herbal Mandi) is 
essentially required. Rigorous effort to be done for 
conservation of rare & endangered plant. 
 Development of GMP/QC & QA training Centers.  
  Publication of various Book/manual on GMP/QC & 
QA. Regular seminar, workshop, ROTP program for 
awareness of GMP/QC & QA standards.  
 Initiatives & Incentive for Quality accreditation.  
 ASU Drug manufacturing needs more assistance 
from Govt from deferent Dept. 
 There are other many suggestion may be taken 
from various stack holder of AYUSH system of Medicines; 
Lets joint hand to all Industry-Academia-Student-Policy 
maker for the development & well-being of our Ayush 
System of Medicines. 
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